UC Irvine researcher Weian Zhao, PhD, has received a grant of $567,373 to develop new treatments to cure metastatic breast cancer.
Zhao will use the funds, awarded by the U.S. Army Medical Research and Materiel Command, to create bioengineered mesenchymal stem cells, or MSCs. These stem cells are currently used in experiments to treat a variety of diseases and they produce very few side effects.
Zhao's study is the first of its kind aimed at developing more effective treatments with MSCs targeting metastatic breast cancers that spread to the lungs.
Zhao, a member of the Chao Family Comprehensive Cancer Center and the Sue and Bill Gross Stem Cell Research Center, believes this approach will offer patients a new kind of therapy without the debilitating side effects commonly experienced with chemotherapy.
Congratulations to the Zhao Lab!